RESEARCH PROJECTS

ECONOMIC PRICE AND PRODUCTIVITY MEASUREMENT IN A PHARMACEUTICAL SUB-SECTOR - TREATING HYPERTENSION

Data sets requested

• Medical Services Plan (BC Ministry of Health)
• Consolidation file (Medical Services Plan Premium Registration and Billing) (BC Ministry of Health)
• PharmaCare (BC Ministry of Health)
• Hospital Separations (BC Ministry of Health)
• Vital Statistics Deaths (BC Vital Statistics Agency)

Publications

Journal articles

Morgan, S.G.; Bassett, K.; Wright, J.; Yan, L. (2005) "First-line first? Trends in thiazide prescribing for BC seniors." PLoS Medicine 2(4): e80-e87

Morgan, S.G.; Yan, L. (2004)  "Persistence with hypertension treatment among community-dwelling BC seniors." Canadian Journal of Clinical Pharmacology 11(2): e267-e273

Morgan, S. (2002) "Quantifying components of drug expenditure inflation: The British Columbia seniors’ drug benefit plan." Health Services Research 37(5): 1243-1266

Morgan, S. (2001) "Statistics and drug utilization: Are prescribing rates really that high?" Canadian Medical Association Journal 165(11): 1507-1508

Conference presentations

Morgan, S; Barer, M.; Agnew, J. "Seniors’ cost-inflation and cost-containment: Evidence from British Columbia." Fourth World Congress of the International Health Economics Association, San Francisco, June 2003

Morgan, S. "Quantifying components of drug expenditure inflation: The British Columbia seniors’ drug benefit plan." Tenth Canadian Conference on Health Economics, Halifax, May 2002

Morgan, S.G. "Productivity measurement in a pharmaceutical sub-sector: The real cost of treating hypertension." 34th Annual Meeting of the Canadian Economics Association, Vancouver, June 2000

Presentations

Morgan, S. "Measuring ‘quality,’ ‘accessibility.’ and ‘sustainability’ – Are drugs part of the problem or part of the solution?” Tools For Advancing Pharmaceuticals Management. Canadian Coordinating Office for Health Technology Assessment; Canadian Institute for Health Information; Health Canada, Therapeutic Products Directorate; and the Patented Medicine Prices Review Board, Ottawa, November 2004

Morgan, S. "Sources of drug spending trends and variations in Canada." Pharmaceutical Policy, hearings of the House of Commons Standing Committee on Health, Vancouver, September 2003

Morgan, S. "Pharmaceuticals as a cost driver in Canada.Toward a National Strategy on Drug Insurance: Challenges and Priorities." Institute for Research on Public Policy, Toronto, September 2002

Morgan, S. "Drug spending trends: The devil in the details." Policy Rounds Forum, British Columbia Ministry of Health and Ministry Responsible for Seniors, Victoria, January 2001.

< back to Research Projects